Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SpineSmith is a biotechnology and medical device company that specializes in the design and development of innovative implants and biologics for the treatment of spinal pathologies. Based in Austin, Texas, the company utilizes a unique "think-tank" approach, collaborating closely with scientists, engineers, and spine surgeons to create integrated biological systems rather than just hardware. Their product portfolio includes advanced spinal fixation systems, 3D-printed implants, and regenerative cell therapies, often leveraging autologous stem cell technology through its partnership with Celling Biosciences. SpineSmith focuses on combining biomaterials science with innovative manufacturing methods like nanotechnology and encapsulation to enhance tissue regeneration and surgical outcomes. The company's commercial offerings include the VisuALIF and IN:C2 systems, which are designed to interface seamlessly with the body's natural biology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SpineSmith.